PGP and osteosarcoma: In our study, the results showed that CRISPR-Cas9 guided by ABCB1 sgRNA markedly decreased P-gp expression in osteosarcoma MDR cell lines, whereas pEGFP-N3 had no effect on KHOSR2 or U-2OSR2 cell lines.